 
        Preemptive analgesia may reduce pain & postop complication following lumbar fusion surgery
 
                                                    Preemptive analgesia may reduce pain & postop complication following lumbar fusion surgery
Preemptive multimodal analgesia for postoperative pain management after lumbar fusion surgery: a randomized controlled trial
Eur Spine J. 2016 May;25(5):1614-9.Synopsis
80 patients with symptomatic lumbar 4-5 stenosis undergoing posterior lumbar interbody fusion (PLIF) were randomized to receive either preemptive multimodal analgesia (celecoxib, pregabalin, oxycodone ER, and acetaminophen) or standard postoperative intravenous morphine. The purpose of this study was to compare pain in the immediate postoperative period and radiographic outcome up to one year afte...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.